PMC:7534795 / 19917-20150
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T96290 | 194-202 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T58937 | 150-151 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T123 | 5-110 | Sentence | denotes | • Improved respiratory function, oxygenation, and pulmonary lesions • Phase 4 study completed in May 2020 |
| T124 | 111-128 | Sentence | denotes | • Results pending |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T86 | 194-219 | Phenotype | denotes | cytokine release syndrome | http://purl.obolibrary.org/obo/HP_0033041 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 681 | 55-72 | Disease | denotes | pulmonary lesions | MESH:D008171 |
| 682 | 121-142 | Disease | denotes | pending • Tocilizumab |